Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print July 15, 2008
DOI: 10.2337/db07-1410

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-1410v1
57/10/2588    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Yuen, N.
Right arrow Articles by O'Donnell, M. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuen, N.
Right arrow Articles by O'Donnell, M. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Cerebral Blood Flow and Cerebral Edema in Rats with Diabetic Ketoacidosis

Natalie Yuen, B.S.1, Steven E. Anderson, Ph.D.1, Nicole Glaser, MD2, Daniel J. Tancredi, Ph.D.2, and Martha E. O'Donnell, Ph.D.1

1Department of Physiology and Membrane Biology and
2Department of Pediatrics, University of California, One Shields Avenue, Davis, CA 95616

OBJECTIVE: Cerebral edema (CE) is a potentially life-threatening complication of DKA in children. Osmotic fluctuations during DKA treatment have been considered responsible, but recent data instead suggest that cerebral hypoperfusion may be involved, and that activation of cerebral ion transporters may occur. Diminished cerebral blood flow (CBF) during DKA, however, has not been previously demonstrated. We investigated CBF and edema formation in a rat model of DKA and determined the effects of bumetanide, an inhibitor of Na-K-Cl cotransport.

RESEARCH DESIGN AND METHODS: Juvenile rats with streptozotocin-induced DKA were treated with intravenous saline and insulin, similar to human treatment protocols. CBF was determined by magnetic resonance (MR) perfusion weighted imaging before and during treatment and CE was assessed by determining apparent diffusion coefficients (ADC) using MR diffusion weighted imaging.

RESULTS: CBF was significantly reduced in DKA and was responsive to alterations in pCO2. ADC values were reduced, consistent with cell swelling. The reduction in ADC correlated with dehydration, as reflected in blood urea nitrogen concentrations. Bumetanide caused a rapid rise in ADC of DKA rats without significantly changing CBF, while saline/insulin caused a rapid rise in CBF and a gradual rise in ADC. DKA rats treated with bumetanide plus saline/insulin showed a trend toward more rapid rise in cortical ADC and a larger rise in striatal CBF than those observed with saline/insulin alone.

CONCLUSIONS: These data demonstrate that CE in DKA is accompanied by cerebral hypoperfusion before treatment and suggest that blocking Na-K-Cl cotransport may reduce cerebral cell swelling.


Correspondence: meodonnell{at}ucdavis.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.